Document is current
Any future updates will be listed below
-
Authors
Media, Ara S.
Juhl-Olesen, Peter
Christensen, Thomas Decker
Katballe, Niels
Vad, Henrik
Petersen, René Horsleben
Wiggers, Henrik
Hansen, Stefan Nygaard
Farup, Jean
Overgaard, Kristian
de Paoli, Frank Vincenzo
- License Information
-
More Information
Article History
Received: 12 September 2024
Accepted: 18 June 2025
First Online: 19 July 2025
Declarations
:
: The authors declare no competing interests.
: Institutional Review Board (IRB) approval was not required since data is extracted from already published papers (Systematic Review and Meta-analysis).
: TDC: Speaker bureaus for Novartis, AstraZeneca, Bristol-Myers Squibb, Chiesi Pharma AB and GSK (GlaxoSmithKline) and has been in an Advisory Board for Merck Sharp & Dohme (MSD), Sanofi and AstraZeneca. RHP: Speaker fee Medtronic, AMBU, Medela, AstraZeneca. Adv. Board: AstraZeneca, BMS, MSD and Roche. All other authors declare no competing interests.
